Development and validation of a method for the quantitative determination of rotenone in the homogenate of the cerebral cortex of rats by high-performance liquid chromatography (HPLC)

Capa

Citar

Texto integral

Resumo

Introduction. Rotenone is a neurotoxin that causes damage of dopaminergic neurons in the substantia nigra and is used as a model for experimental parkinsonian syndrome. The development of a technique for the quantitative determination of rotenone in the brain will allow testing new strategies for the pharmacotherapy of parkinsonism by reducing the penetration of toxic substances into the brain.

The aim of the study was to develop and validate an HPLC method for the quantitative determination of rotenone in the cerebral cortex of rats.

Material and methods. Quantitative determination of rotenone was carried out using a Stayer chromatographic system (Аквилон, Russia) with a UV spectrophotometric detector UVV 104 at a wavelength of 296 nm in isocratic mode. A reverse-phase chromatographic column Luna C18 100Å (250*4.6) with a grain size of 5 μm at a temperature of 37°C was used. The composition of the mobile phase was deionized water, acetonitrile in a ratio of 70:30. Determination of rotenone concentration was carried out by the method of absolute calibration by the area of the peaks.

Sample preparation consisted in homogenization of 500 mg of crushed frontal lobe of the rat cerebral cortex in 500 μl of purified water, followed by centrifugation (1750 g), collection of the supernatant and sedimentation of the proteins by acetonitrile. The liquid layer was evaporated on a rotary vacuum. 250 µl of the mobile phase was added to the dry residue, and 100 µl was injected into the chromatograph.

Results. The method was validated for the following parameters: selectivity, linearity, accuracy, precision, limits of detection and determination, sample transfer, sample stability. The analytical range was 62.5−1000.0 ng/g brain with a correlation coefficient of more than 0.99. The limits of detection and quantification of rotenone were 25.0 and 62.5 ng/g, respectively. The calculation of intra- and inter-cycle accuracy and precision showed that these parameters do not exceed 20% for the concentration corresponding to the lower limit of quantitative determination, and 15% for higher concentrations. The stability of the technique was demonstrated during short-term storage at room temperature, three freeze-thaw cycles at –80°C, and storage at –80°C for 60 days. There was no sample transfer.

Limitations. The chromatographic technique makes it possible to analyze the content of rotenone in the cerebral cortex of rats in the concentration range of 62.5–1000.0 ng/g.

Conclusion. A method for the quantitative determination of rotenone in the homogenate of the cerebral cortex of rats has been developed and validated.

Compliance with ethical standards. The experimental study was approved by the commission for control over the maintenance and use of laboratory animals of the Ryazan State Medical University.

Author contribution:
Gradinar M.M. — performance of chromatographic studies, sample preparation;
Shchulkin A.V. — statistical processing of the obtained results, writing an article;
Chernykh I.V. — performance of chromatographic studies, calculation of validation parameters;
Yakusheva E.N. — writing an article, general management of the work.
All co-authors — approval of the final version of the article, responsibility for the integrity of all parts of the article.

Conflict of interests. The authors declare no conflict of interest.

Funding. The study was not sponsored.

Received: January 1, 2023 / Accepted: February 2,2023 / Published: April 30, 2023

Palavras-chave

Sobre autores

Maria Gradinar

Ryazan State Medical University

Autor responsável pela correspondência
Email: masha.gradinar1995@mail.ru
ORCID ID: 0000-0002-2246-4127
Rússia

Alexey Shchulkin

Ryazan State Medical University

Email: alekseyshulkin@rambler.ru
ORCID ID: 0000-0003-1688-0017
Rússia

Ivan Chernykh

Ryazan State Medical University

Email: ivchernykh88@mail.ru
ORCID ID: 0000-0002-5618-7607

Doctor of Biological Sciences, Associate Professor, Head of the Department of Pharmaceutical Chemistry, Ryazan State Medical University, Ministry of Health of Russia, 390026, Ryazan, Russian Federation.

e-mail: ivchernykh88@mail.ru

Rússia

Elena Yakusheva

Ryazan State Medical University

Email: e.yakusheva@rzgmu.ru
ORCID ID: 0000-0001-6887-4888
Rússia

Bibliografia

  1. Sherer T.B., Betarbet R., Testa C.M., Seo B.B., Richardson J.R., Kim J.H., et al. Mechanism of toxicity in rotenone models of Parkinson’s disease. Journal of Neuroscience. 2003; 23(34): 10756–64. https://doi.org/10.1523/JNEUROSCI.23-34-10756.2003
  2. Watabe M., Nakaki T. Mitochondrial complex I inhibitor rotenone inhibits and redistributes vesicular monoamine transporter 2 via nitration in human dopaminergic SH-SY5Y cells. Molecular Pharmacology. 2008; 74: 933–40. https://doi.org/10.1124/mol.108.048546
  3. Alam M., Schmidt W.J. l-DOPA reverses the hypokinetic behavior and rigidity in rotenone-treated rats. Behavioural Brain Research. 2004; 153: 439–46. https://doi.org/10.1016/j.bbr.2003.12.021
  4. Betarbet R., Sherer T.В., Greenamyre J.T. Animal models of Parkinson Disease. Bioessays. 2002; 24(4): 308–18. https://doi.org/10.1002/bies.10067
  5. De Miranda B.R., Fazzari M., Rocha E.M., Castro S., Greenamyre J.T. Sex differences in rotenone sensitivity reflect the male-to-female ratio in human Parkinson’s disease incidence. Toxicol Sci. 2019; 170(1): 133−43. https://doi.org/10.1093/toxsci/kfz082
  6. Caboni P., Sarais G., Vargiu S., Luca M.A., Garau V.L., Ibba A., Cabras P. LC–MS–MS Determination of Rotenone, Deguelin, and Rotenolone in Human Serum. Chromatographia. 2008; 68: 739−45. https://doi.org/10.1365/s10337-008-0830-0
  7. Di Donna L., Grassi G., Mazzotti F., Perri E., Sindona G. High-throughput assay of rotenone in olive oil using atmospheric pressure chemical ionization tandem mass spectrometry. Journal of Mass Spectrometry. 2004; 39(12): 1437−40. https://doi.org/10.1002/jms.694
  8. Taylor M.J., Keenan G.A., Reid K.B., Fernandez D.U. The utility of ultra-performance liquid chromatography/electrospray ionisation time-of-flight mass spectrometry for multi-residue determination of pesticides in strawberry. Rapid Communications in Mass Spectrometry. 2008; 22(17): 2731−46. https://doi.org/10.1002/rcm.3671
  9. Huang J., Liu H., Gu W., Yan Z., Xu Z., Yang Y., et al. A delivery strategy for rotenone microspheres in an animal model of Parkinson’s disease. Biomaterials. 2006; 27: 937−46. https://doi.org/10.1016/j.biomaterials.2005.07.005
  10. Chernykh I.V., Shchulkin A.V., Mylnikov P.Y. Functional activity of p-glycoprotein in blood-brain barrier during experimental parkinson’s syndrome. Rossijskij mediko-biologicheskij vestnik imeni akademika I.P. Pavlova. 2019; 27(2): 150–9. https://doi.org/10.23888/PAVLOVJ2019272150-159 (in Russian)
  11. Mylnikov P.Yu., Chernykh I.V., Shchulkin A.V., Popova N.M., Yakusheva E.N. HPLC-methods of fexofenadine quantitative analysis in rabbits’ liver. Farmaciya i farmakologiya. 2020; 8(1): 40–47. https://doi.org/10.19163/2307-9266-2020-8-1-40-47 (in Russian)

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Gradinar M.M., Shchulkin A.V., Chernykh I.V., Yakusheva E.N., 2023



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 81728 от 11 декабря 2013.